BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nara S, Esaki M, Ban D, Takamoto T, Shimada K, Ioka T, Okusaka T, Ishii H, Furuse J. Adjuvant and neoadjuvant therapy for biliary tract cancer: a review of clinical trials. Jpn J Clin Oncol 2020;50:1353-63. [PMID: 33037430 DOI: 10.1093/jjco/hyaa170] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Kunitoh H. Message from the Editor-in-Chief. Jpn J Clin Oncol 2021;51:1-2. [PMID: 33367846 DOI: 10.1093/jjco/hyaa205] [Reference Citation Analysis]
2 Hamura R, Haruki K, Taniai T, Yanagaki M, Shirai Y, Furukawa K, Usuba T, Fujioka S, Okamoto T, Nakabayashi Y, Uwagawa T, Ikegami T. The impact of S-1 for the patient with lymph nodal metastasis biliary tract cancer as adjuvant chemotherapy: a multicenter database analysis. Int J Clin Oncol. [DOI: 10.1007/s10147-022-02165-1] [Reference Citation Analysis]
3 Kunitoh H. Message from the Editor-in-Chief. Jpn J Clin Oncol 2022;52:1-2. [PMID: 34978327 DOI: 10.1093/jjco/hyab190] [Reference Citation Analysis]
4 Posch F, Prinz F, Balihodzic A, Mayr C, Kiesslich T, Klec C, Jonas K, Barth DA, Riedl JM, Gerger A, Pichler M. MiR-200c-3p Modulates Cisplatin Resistance in Biliary Tract Cancer by ZEB1-Independent Mechanisms. Cancers (Basel) 2021;13:3996. [PMID: 34439151 DOI: 10.3390/cancers13163996] [Reference Citation Analysis]
5 Nara S, Esaki M, Ban D, Takamoto T, Mizui T, Shimada K. Role of adjuvant and neoadjuvant therapy for resectable biliary tract cancer. Expert Rev Gastroenterol Hepatol 2021;15:537-45. [PMID: 33793366 DOI: 10.1080/17474124.2021.1911645] [Reference Citation Analysis]
6 Papamichail M, Pizanias M, Heaton ND, M P, M P, Nd H. Minimizing the risk of small-for-size syndrome after liver surgery. Hepatobiliary Pancreat Dis Int 2021:S1499-3872(21)00230-7. [PMID: 34961675 DOI: 10.1016/j.hbpd.2021.12.005] [Reference Citation Analysis]
7 Xiao X, Zhou J, Fang M, Ji J, Huang C, Du F, Ai W, Wang Y, Gao Z, Qiu Z, Gao C. Quantitative detections of TP53 gene mutations improve the diagnosis and prognostic prediction of biliary tract cancers using droplet digital PCR. J Clin Lab Anal 2021;:e24103. [PMID: 34813121 DOI: 10.1002/jcla.24103] [Reference Citation Analysis]
8 Bahra M. [Surgical treatment of distal cholangiocarcinoma]. Chirurg 2021;92:788-95. [PMID: 34232340 DOI: 10.1007/s00104-021-01453-2] [Reference Citation Analysis]